Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

GLUT12 Expression in Brain of Mouse Models of Alzheimer's Disease.

Gil-Iturbe E, Solas M, Cuadrado-Tejedo M, García-Osta A, Escoté X, Ramírez MJ, Lostao MP.

Mol Neurobiol. 2019 Aug 31. doi: 10.1007/s12035-019-01743-1. [Epub ahead of print]

PMID:
31473905
2.

Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target.

Janeiro MH, Ramírez MJ, Milagro FI, Martínez JA, Solas M.

Nutrients. 2018 Oct 1;10(10). pii: E1398. doi: 10.3390/nu10101398. Review.

3.

Reduced Adrenomedullin Parallels Microtubule Dismantlement in Frontotemporal Lobar Degeneration.

Ferrero H, Larrayoz IM, Solas M, Martínez A, Ramírez MJ, Gil-Bea FJ.

Mol Neurobiol. 2018 Dec;55(12):9328-9333. doi: 10.1007/s12035-018-1079-8. Epub 2018 Apr 18.

PMID:
29671277
4.

Pegylated nanoparticles for the oral delivery of nimodipine: Pharmacokinetics and effect on the anxiety and cognition in mice.

Moreno LCGEAI, Solas M, Martínez-Ohárriz MC, Muñoz E, Santos-Magalhães NS, Ramirez MJ, Irache JM.

Int J Pharm. 2018 May 30;543(1-2):245-256. doi: 10.1016/j.ijpharm.2018.03.048. Epub 2018 Mar 28.

PMID:
29604372
5.

Inflammation and gut-brain axis link obesity to cognitive dysfunction: plausible pharmacological interventions.

Solas M, Milagro FI, Ramírez MJ, Martínez JA.

Curr Opin Pharmacol. 2017 Dec;37:87-92. doi: 10.1016/j.coph.2017.10.005. Epub 2017 Nov 5. Review.

PMID:
29107872
6.

Increased Levels of Brain Adrenomedullin in the Neuropathology of Alzheimer's Disease.

Ferrero H, Larrayoz IM, Martisova E, Solas M, Howlett DR, Francis PT, Gil-Bea FJ, Martínez A, Ramírez MJ.

Mol Neurobiol. 2018 Jun;55(6):5177-5183. doi: 10.1007/s12035-017-0700-6. Epub 2017 Sep 2.

PMID:
28866832
7.

Exploring Pharmacological Mechanisms of Lavender (Lavandula angustifolia) Essential Oil on Central Nervous System Targets.

López V, Nielsen B, Solas M, Ramírez MJ, Jäger AK.

Front Pharmacol. 2017 May 19;8:280. doi: 10.3389/fphar.2017.00280. eCollection 2017.

8.

Serotonin 5-HT6 Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status.

Ferrero H, Solas M, Francis PT, Ramirez MJ.

CNS Drugs. 2017 Jan;31(1):19-32. doi: 10.1007/s40263-016-0399-3. Review.

PMID:
27914038
9.

Myeloid-Cell-Derived VEGF Maintains Brain Glucose Uptake and Limits Cognitive Impairment in Obesity.

Jais A, Solas M, Backes H, Chaurasia B, Kleinridders A, Theurich S, Mauer J, Steculorum SM, Hampel B, Goldau J, Alber J, Förster CY, Eming SA, Schwaninger M, Ferrara N, Karsenty G, Brüning JC.

Cell. 2016 Aug 25;166(5):1338-1340. doi: 10.1016/j.cell.2016.08.010. No abstract available.

10.

Down-regulation of glutamatergic terminals (VGLUT1) driven by Aβ in Alzheimer's disease.

Rodriguez-Perdigon M, Tordera RM, Gil-Bea FJ, Gerenu G, Ramirez MJ, Solas M.

Hippocampus. 2016 Oct;26(10):1303-12. doi: 10.1002/hipo.22607. Epub 2016 Jun 21.

PMID:
27258819
11.

Precision Obesity Treatments Including Pharmacogenetic and Nutrigenetic Approaches.

Solas M, Milagro FI, Martínez-Urbistondo D, Ramirez MJ, Martínez JA.

Trends Pharmacol Sci. 2016 Jul;37(7):575-593. doi: 10.1016/j.tips.2016.04.008. Epub 2016 May 25. Review.

PMID:
27236593
12.

Myeloid-Cell-Derived VEGF Maintains Brain Glucose Uptake and Limits Cognitive Impairment in Obesity.

Jais A, Solas M, Backes H, Chaurasia B, Kleinridders A, Theurich S, Mauer J, Steculorum SM, Hampel B, Goldau J, Alber J, Förster CY, Eming SA, Schwaninger M, Ferrara N, Karsenty G, Brüning JC.

Cell. 2016 May 5;165(4):882-95. doi: 10.1016/j.cell.2016.03.033. Epub 2016 Apr 28. Erratum in: Cell. 2016 Aug 25;166(5):1338-1340.

13.

JNK: A Putative Link Between Insulin Signaling and VGLUT1 in Alzheimer's Disease.

Rodriguez-Perdigon M, Solas M, Ramirez MJ.

J Alzheimers Dis. 2016;50(4):963-7. doi: 10.3233/JAD-150659.

PMID:
26836159
14.

c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's Disease.

Yarza R, Vela S, Solas M, Ramirez MJ.

Front Pharmacol. 2016 Jan 12;6:321. doi: 10.3389/fphar.2015.00321. eCollection 2015. Review.

15.

Lipoic acid improves neuronal insulin signalling and rescues cognitive function regulating VGlut1 expression in high-fat-fed rats: Implications for Alzheimer's disease.

Rodriguez-Perdigon M, Solas M, Moreno-Aliaga MJ, Ramirez MJ.

Biochim Biophys Acta. 2016 Apr;1862(4):511-517. doi: 10.1016/j.bbadis.2016.01.004. Epub 2016 Jan 6.

16.

Treatment Options in Alzheimer´s Disease: The GABA Story.

Solas M, Puerta E, Ramirez MJ.

Curr Pharm Des. 2015;21(34):4960-71. Review.

PMID:
26365140
17.

Venlafaxine reverses decreased proliferation in the subventricular zone in a rat model of early life stress.

Martisova E, Aisa B, Tordera RM, Puerta E, Solas M, Ramirez MJ.

Behav Brain Res. 2015 Oct 1;292:79-82. doi: 10.1016/j.bbr.2015.05.059. Epub 2015 Jun 5.

PMID:
26051818
18.

The paradox of neuronal insulin action and resistance in the development of aging-associated diseases.

Steculorum SM, Solas M, Brüning JC.

Alzheimers Dement. 2014 Feb;10(1 Suppl):S3-11. doi: 10.1016/j.jalz.2013.12.008. Review.

PMID:
24529522
19.

Stress contributes to the development of central insulin resistance during aging: implications for Alzheimer's disease.

Solas M, Aisa B, Tordera RM, Mugueta MC, Ramírez MJ.

Biochim Biophys Acta. 2013 Dec;1832(12):2332-9. doi: 10.1016/j.bbadis.2013.09.013. Epub 2013 Oct 1.

20.

CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients.

Solas M, Francis PT, Franco R, Ramirez MJ.

Neurobiol Aging. 2013 Mar;34(3):805-8. doi: 10.1016/j.neurobiolaging.2012.06.005. Epub 2012 Jul 2.

PMID:
22763024

Supplemental Content

Loading ...
Support Center